Role of the Chief Executive Officer in preventing lapses in ethical standard
Posted by Terence Chua, Year 4 undergrad at the School of Business, Singapore Management University
I remember an article I read from Bloomberg, “AIG of Drugmakers Pfizer Is Too Big to Be Guilty” -http://www.bloomberg.com/apps/news?pid=newsarchive&sid=ahodmf54hyPA
Brief summary: Pfizer sales personnels blatantly ignore negative health consequences to push drug with detrimental health consequences. Despite being fined repeatedly for such lapses in the past, regulatory authorities have found it difficult to come up with a strong enough punishment to prevent Pfizer from committing such a lapse because the bankruptcy of Pfizer will lead to greater detriments to society; if Pfizer is convicted of crime, they would face debarment from federal programs. And that would mean that Medicaid and Medicare patients would have to either somehow pay pocket for vital medicines the company produces or go without. With such a consideration, Pfizer’s senior executives continue to flout laws without much consideration of the consequences of their actions.
So what does the above article have in reference to accounting fraud? Continue reading